Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy
With 185 million people chronically infected globally, hepatitis C is a leading bloodborne infection. All-oral regimens of direct acting agents have superior efficacy compared to the historical interferon-based regimens and are significantly more tolerable. However, trials of both types of regimens...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
XIA & HE Publishing Inc.
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075004/ |